Vetr upgraded Valeant Pharmaceuticals International Inc. (NYSE: VRX) from 4 stars to 5 stars sending the stock price up $2.07 to close at $19.70.
Valeant Pharmaceuticals upgraded
December 08, 2017 at 17:22 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|